CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy
Sol Aldrete(Emory University), Vincent C. Marconi(Emory University), Ryan C. Maves(Naval Medical Center San Diego), Tian Dai(Hunan Cancer Hospital), Yi No Chen(Emory University), Kirk A. Easley(Emory University), Mirko Paiardini(Oregon National Primate Research Center), María Pino(Translational Research Institute), Brian K. Agan(Henry M. Jackson Foundation), Jason F. Okulicz(Gilead Sciences (United States)), Jeong Hoon Jang(Emory University)
Cited by 18
Related Papers
Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
|Blood|2008|638
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
Correlation between ammonia levels and the severity of hepatic encephalopathy
|The American Journal of Medicine|2003|542
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
|PLoS Pathogens|2010|468
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367